Measurement of the clinical status of patients with breast cancer: evidence for the validity of self assessment with linear analogue scales.
We have assessed the validity of a method of measurement for describing the clinical status of patients with breast cancer. One hundred and nine patients with breast cancer assigned numerical values to their own state of health using linear analogue scales. We have shown previously that this method of measurement is reliable and corresponds well with other methods of assessment. Validity was assessed in this study by examining the ability of measurements to distinguish between groups of patients who differed either in the presence of metastatic disease or in the treatments they were receiving. All patients completed the same set of 29 linear analogue scales that enquired about the severity of health related problems and symptoms. In general, patients with metastatic disease were clearly distinguished from patients without metastases by their scores on items related to physical function. Patients receiving chemotherapy were distinguished from those not receiving chemotherapy by their scores on treatment related toxicities. Measures of psychological and social health were similar in patients receiving chemotherapy regardless of disease status. These results provide further support for the validity of measurement of clinical status with linear analogue scales scored by patients.
Boyd
N F
NF
Department of Medicine, Ontario Cancer Institute, Toronto, Canada.
Selby
P J
PJ
Sutherland
H J
HJ
Hogg
S
S
D001943:Breast Neoplasms / Q000503:physiopathology* / Q000523:psychology / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006262:Health; D006304:Health Status; D006801:Humans; D009362:Neoplasm Metastasis; D011788:Quality of Life; D012647:Self-Assessment; D011795:Surveys and Questionnaires